Codiak Financial Statements From 2010 to 2024
| CDAKDelisted Stock | USD 0.01 0 14.15% |
Check Codiak BioSciencesInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Codiak main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Codiak financial statements analysis is a perfect complement when working with Codiak BioSciencesInc Valuation or Volatility modules.
Codiak |
Codiak BioSciencesInc Company Operating Margin Analysis
Codiak BioSciencesInc's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Codiak BioSciencesInc Operating Margin | (1.54) % |
Most of Codiak BioSciencesInc's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Codiak BioSciencesInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Codiak BioSciencesInc has an Operating Margin of -1.5441%. This is 95.6% lower than that of the Biotechnology sector and 98.62% lower than that of the Health Care industry. The operating margin for all United States stocks is 71.98% lower than that of the firm.
Codiak BioSciencesInc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Codiak BioSciencesInc's current stock value. Our valuation model uses many indicators to compare Codiak BioSciencesInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Codiak BioSciencesInc competition to find correlations between indicators driving Codiak BioSciencesInc's intrinsic value. More Info.Codiak BioSciencesInc is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Codiak BioSciencesInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Codiak BioSciencesInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Codiak BioSciencesInc's earnings, one of the primary drivers of an investment's value.About Codiak BioSciencesInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Codiak BioSciencesInc income statement, its balance sheet, and the statement of cash flows. Codiak BioSciencesInc investors use historical funamental indicators, such as Codiak BioSciencesInc's revenue or net income, to determine how well the company is positioned to perform in the future. Although Codiak BioSciencesInc investors may use each financial statement separately, they are all related. The changes in Codiak BioSciencesInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Codiak BioSciencesInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Codiak BioSciencesInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Codiak BioSciencesInc. Please read more on our technical analysis and fundamental analysis pages.
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Codiak Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Codiak BioSciencesInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Codiak BioSciencesInc's short interest history, or implied volatility extrapolated from Codiak BioSciencesInc options trading.
Pair Trading with Codiak BioSciencesInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Codiak BioSciencesInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciencesInc will appreciate offsetting losses from the drop in the long position's value.Moving against Codiak Stock
| 0.91 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.89 | DIS | Walt Disney Report 8th of May 2024 | PairCorr |
| 0.88 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
| 0.85 | TSM | Taiwan Semiconductor Financial Report 18th of July 2024 | PairCorr |
| 0.8 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
The ability to find closely correlated positions to Codiak BioSciencesInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Codiak BioSciencesInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Codiak BioSciencesInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Codiak BioSciencesInc to buy it.
The correlation of Codiak BioSciencesInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Codiak BioSciencesInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Codiak BioSciencesInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Codiak BioSciencesInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Codiak BioSciencesInc information on this page should be used as a complementary analysis to other Codiak BioSciencesInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Codiak Stock
If you are still planning to invest in Codiak BioSciencesInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Codiak BioSciencesInc's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |